Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2014 1
2015 1
2016 2
2017 1
2018 1
2019 3
2020 2
2021 2
2022 1
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Amentoflavone as an Ally in the Treatment of Cutaneous Leishmaniasis: Analysis of Its Antioxidant/Prooxidant Mechanisms.
Rizk YS, Santos-Pereira S, Gervazoni L, Hardoim DJ, Cardoso FO, de Souza CDSF, Pelajo-Machado M, Carollo CA, de Arruda CCP, Almeida-Amaral EE, Zaverucha-do-Valle T, Calabrese KDS. Rizk YS, et al. Front Cell Infect Microbiol. 2021 Feb 25;11:615814. doi: 10.3389/fcimb.2021.615814. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33718267 Free PMC article.
Design, synthesis, antileishmanial, and antifungal biological evaluation of novel 3,5-disubstituted isoxazole compounds based on 5-nitrofuran scaffolds.
Trefzger OS, Barbosa NV, Scapolatempo RL, das Neves AR, Ortale MLFS, Carvalho DB, Honorato AM, Fragoso MR, Shuiguemoto CYK, Perdomo RT, Matos MFC, Chang MR, Arruda CCP, Baroni ACM. Trefzger OS, et al. Among authors: arruda ccp. Arch Pharm (Weinheim). 2020 Feb;353(2):e1900241. doi: 10.1002/ardp.201900241. Epub 2019 Dec 16. Arch Pharm (Weinheim). 2020. PMID: 31840866
In Vivo Antileishmanial Effect of 3,5-Diaryl-isoxazole Analogues Based on Veraguensin, Grandisin, and Machilin G: A Glance at a Preclinical Study.
das Neves AR, Carvalho DB, Silva F, Rosalem RF, Pelizaro BI, Castilho PF, Oliveira KMP, Cassemiro NS, Pessatto LR, Paredes-Gamero EJ, Piranda EM, Silva DB, Arruda CCP, Baroni ACM. das Neves AR, et al. Among authors: arruda ccp. ACS Infect Dis. 2023 May 12;9(5):1150-1159. doi: 10.1021/acsinfecdis.3c00090. Epub 2023 Apr 27. ACS Infect Dis. 2023. PMID: 37103973
Design, synthesis and antitrypanosomatid activities of 3,5-diaryl-isoxazole analogues based on neolignans veraguensin, grandisin and machilin G.
Trefzger OS, das Neves AR, Barbosa NV, Carvalho DB, Pereira IC, Perdomo RT, Matos MFC, Yoshida NC, Kato MJ, de Albuquerque S, Arruda CCP, Baroni ACM. Trefzger OS, et al. Among authors: arruda ccp. Chem Biol Drug Des. 2019 Mar;93(3):313-324. doi: 10.1111/cbdd.13417. Epub 2018 Nov 25. Chem Biol Drug Des. 2019. PMID: 30354012
Design, synthesis and antitrypanosomatid activity of 2-nitroimidazole-3,5-disubstituted isoxazole compounds based on benznidazole.
Carvalho DB, Costa PAN, Portapilla GB, das Neves AR, Shiguemoto CYK, Pelizaro BI, Silva F, Piranda EM, Arruda CCP, Gaspari PDM, Cardoso IA, Luccas PH, Nonato MC, Lopes NP, de Albuquerque S, Baroni ACM. Carvalho DB, et al. Among authors: arruda ccp. Eur J Med Chem. 2023 Nov 15;260:115451. doi: 10.1016/j.ejmech.2023.115451. Epub 2023 May 5. Eur J Med Chem. 2023. PMID: 37573209
Investigation of the Potential Targets behind the Promising and Highly Selective Antileishmanial Action of Synthetic Flavonoid Derivatives.
Lourenço EMG, da Silva F, das Neves AR, Bonfá IS, Ferreira AMT, Menezes ACG, da Silva MEC, Dos Santos JT, Martines MAU, Perdomo RT, Toffoli-Kadri MC, G Barbosa E, Saba S, Beatriz A, Rafique J, de Arruda CCP, de Lima DP. Lourenço EMG, et al. Among authors: de arruda ccp. ACS Infect Dis. 2023 Oct 13;9(10):2048-2061. doi: 10.1021/acsinfecdis.3c00336. Epub 2023 Sep 29. ACS Infect Dis. 2023. PMID: 37772925
19 results